Spyre Therapeutics, Inc. (SYRE)

Revance Therapeutics Statistics

Total Valuation

SYRE has a market cap or net worth of $981.05 million. The enterprise value is $416.53 million.

Market Cap	981.05M
Enterprise Value	416.53M

Important Dates

The next estimated earnings date is Friday, August 15, 2025, after market close.

Earnings Date	Aug 15, 2025
Ex-Dividend Date	n/a

Share Statistics

SYRE has 60.35 million shares outstanding. The number of shares has increased by 251.17% in one year.

Current Share Class	60.35M
Shares Outstanding	60.35M
Shares Change (YoY)	+251.17%
Shares Change (QoQ)	+9.06%
Owned by Insiders (%)	8.72%
Owned by Institutions (%)	93.56%
Float	46.62M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	3.00
P/TBV Ratio	3.00
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 8.06

Current Ratio	8.06
Quick Ratio	8.04
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -65.82% and return on invested capital (ROIC) is -42.20%.

Return on Equity (ROE)	-65.82%
Return on Assets (ROA)	-25.34%
Return on Invested Capital (ROIC)	-42.20%
Return on Capital Employed (ROCE)	-42.95%
Revenue Per Employee	n/a
Profits Per Employee	-$2.45M
Employee Count	65
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, SYRE has paid $4,000 in taxes.

Income Tax	4,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -40.89% in the last 52 weeks. The beta is 2.83, so SYRE's price volatility has been higher than the market average.

Beta (5Y)	2.83
52-Week Price Change	-40.89%
50-Day Moving Average	16.17
200-Day Moving Average	20.84
Relative Strength Index (RSI)	48.34
Average Volume (20 Days)	568,170

Short Selling Information

The latest short interest is 13.60 million, so 22.54% of the outstanding shares have been sold short.

Short Interest	13.60M
Short Previous Month	13.49M
Short % of Shares Out	22.54%
Short % of Float	29.18%
Short Ratio (days to cover)	19.49

Income Statement

Revenue	n/a
Gross Profit	-169.49M
Operating Income	-214.36M
Pretax Income	-185.95M
Net Income	-159.24M
EBITDA	n/a
EBIT	-214.36M
Earnings Per Share (EPS)	-$3.01

Balance Sheet

The company has $564.82 million in cash and n/a in debt, giving a net cash position of $564.82 million or $9.36 per share.

Cash & Cash Equivalents	564.82M
Total Debt	n/a
Net Cash	564.82M
Net Cash Per Share	$9.36
Equity (Book Value)	482.61M
Book Value Per Share	5.42
Working Capital	499.09M

Cash Flow

Operating Cash Flow	-169.86M
Capital Expenditures	n/a
Free Cash Flow	-169.86M
FCF Per Share	-$2.81

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

SYRE does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-251.17%
Shareholder Yield	-251.17%
Earnings Yield	-16.23%
FCF Yield	-17.31%

Analyst Forecast

The average price target for SYRE is $55.00, which is 238.36% higher than the current price. The consensus rating is "Buy".

Price Target	$55.00
Price Target Difference	238.36%
Analyst Consensus	Buy
Analyst Count	5
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	3.47%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on September 8, 2023. It was a reverse split with a ratio of 1:25.

Last Split Date	Sep 8, 2023
Split Type	Reverse
Split Ratio	1:25

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a